BetterTesting.org.uk
Latest news
Version 2.4
Feedback
Please contact us with your comments, so we can improve the website.
In print
These reviews were published in the Journal of Clinical Pathology and a supporting series of cases in the British Medical Journal. See Authors and acknowledgments.
References
All references with links to [Free Full-text] are freely available online to users in England and Wales. This includes the full text of Department of Health papers and Cochrane Library reviews.
1.AGA (2002) American Gastroenterological Association medical position statement: evaluation of liver chemistry tests. Gastroenterology 123(4), 1364-1366.
2.Aranda-Michel, J. and Sherman, K.E. (1998) Tests of the liver: use and misuse. Gastroenterologist 6(1), 34-43. [Abstract]
3.Bland, J.M. and Altman, D.G. (1994) Regression towards the mean. British Medical Journal 308(6942), 1499. [Free Full-text]
4.Bosma, P.J., Chowdhury, J.R., Bakker, C. et al. (1995) The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. New England Journal of Medicine 333(18), 1171-1175. [Abstract] [Free Full-text]
5.British Columbia Medical Association (2004a) Evaluation and interpretation of abnormal liver chemistry in adults. Guidelines and Protocols Advisory Committee. www.health.gov.bc.ca [Accessed: 28/04/2009]. [Free Full-text]
6.British Liver Trust (2002) Fatty liver. Liver diseases. British Liver Trust. www.britishlivertrust.org.uk [Accessed: 22/03/2007].
7.Cooper, C., Dennison, E., Schafheutle, K. et al. (1999) Epidemiology of Paget's disease of bone. Bone Joint Surgery 24(5 Suppl), 3S-5S.
8.Daniel, S., Ben-Menachem, T., Vasudevan, G. et al. (1999) Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. American Journal of Gastroenterology 94(10), 3010-3014. [Abstract]
9.de Marco, R., Locatelli, F., Zoppini, G. et al. (1999) Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. Diabetes Care 22(5), 756-761. [Abstract] [Free Full-text]
10.Gholson, C.F., Morgan, K., Catinis, G. et al. (1997) Chronic hepatitis C with normal aminotransferase levels: a clinical histologic study. American Journal of Gastroenterology 92(10), 1788-1792. [Abstract]
11.Giannini, E.G., Testa, R. and Savarino, V. (2005) Liver enzyme alteration: a guide for clinicians. Canadian Medical Association Journal 172(3), 367-379. [Abstract] [Free Full-text]
12.Giboney, P.T. (2005) Mildly elevated liver transaminase levels in the asymptomatic patient. American Family Physician 71(6), 1105-1110. [Abstract] [Free Full-text]
13.Green, R.M. and Flamm, S. (2002) AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 123(4), 1367-1384.
14.Harrison, S.A., Kadakia, S., Lang, K.A. and Schenker, S. (2002) Nonalcoholic steatohepatitis: what we know in the new millennium. American Journal of Gastroenterology 97(11), 2714-2724. [Abstract]
15.Hay, J.E., Czaja, A.J., Rakela, J. and Ludwig, J. (1989) The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Hepatology 9(2), 193-197. [Abstract]
16.Hietala, J., Puukka, K., Koivisto, H. et al. (2005) Serum gamma-glutamyl transferase in alcoholics, moderate drinkers and abstainers: effect on gt reference intervals at population level. Alcohol and Alcoholism 40(6), 511-514. [Abstract] [Free Full-text]
17.Hultcrantz, R. and Gabrielsson, N. (1993) Patients with persistent elevation of aminotransferases: investigation with ultrasonography, radionuclide imaging and liver biopsy. Journal of Internal Medicine 233(1), 7-12. [Abstract]
18.Hultcrantz, R., Glaumann, H., Lindberg, G. and Nilsson, L.H. (1986) Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases. Scandinavian Journal of Gastroenterology 21(1), 109-113. [Abstract]
19.Ireland, A., Hartley, L., Ryley, N. et al. (1991) Raised gamma-glutamyltransferase activity and the need for liver biopsy. British Medical Journal 302(6773), 388-389. [Abstract] [Free Full-text]
20.Keating, G.M. and Plosker, G.L. (2005) Peginterferon alpha-2a (40KD) plus ribavirin: a review of its use in the management of patients with chronic hepatitis C and persistently 'normal' ALT levels. Drugs 65(4), 521-536. [Abstract]
21.Kim, H.C., Nam, C.M., Jee, S.H. et al. (2004) Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. British Medical Journal 328(7446), 983. [Abstract] [Free Full-text]
22.Kotowicz, M.A. (2004) Paget disease of bone. Diagnosis and indications for treatment. Australian Family Physician 33(3), 127-131. [Abstract]
23.Limdi, J.K. and Hyde, G.M. (2003) Evaluation of abnormal liver function tests. Postgraduate Medical Journal 79(932), 307-312. [Abstract] [Free Full-text]
24.Mathiesen, U.L., Franzen, L.E., Fryden, A. et al. (1999) The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients. Scandinavian Journal of Gastroenterology 34(1), 85-91. [Abstract]
25.McCullough, A.J. (2002) Update on nonalcoholic fatty liver disease. Journal of Clinical Gastroenterology 34(3), 255-262. [Abstract]
26.Minuk, G.Y. (1998) Canadian Association of Gastroenterology Practice Guidelines: evaluation of abnormal liver enzyme tests. Canadian Journal of Gastroenterology 12(6), 417-421.
27.Mofrad, P., Contos, M.J., Haque, M. et al. (2003) Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 37(6), 1286-1292. [Abstract]
28.Moussavian, S.N., Becker, R.C., Piepmeyer, J.L. et al. (1985) Serum gamma-glutamyl transpeptidase and chronic alcoholism. Influence of alcohol ingestion and liver disease. Digestive Diseases and Sciences 30(3), 211-214. [Abstract]
29.Nomura, F., Ohnishi, K., Satomura, Y. et al. (1986) Liver function in moderate obesity–study in 534 moderately obese subjects among 4613 male company employees. International Journal of Obesity 10(5), 349-354. [Abstract]
30.Orrego, H., Blake, J.E. and Israel, Y. (1985) Relationship between gamma-glutamyl transpeptidase and mean urinary alcohol levels in alcoholics while drinking and after alcohol withdrawal. Alcohol, Clinical and Experimental Research 9(1), 10-13. [Abstract]
31.Pratt, D.S. and Kaplan, M.M. (2000) Evaluation of abnormal liver-enzyme results in asymptomatic patients. New England Journal of Medicine 342(17), 1266-1271.
32.Quinn, P.G. and Johnston, D.E. (1997) Detection of chronic liver disease: costs and benefits. Gastroenterologist 5(1), 58-77. [Abstract]
33.Sherwood, P., Lyburn, I., Brown, S. and Ryder, S. (2001) How are abnormal results for liver function tests dealt with in primary care? Audit of yield and impact. British Medical Journal 322(7281), 276-278. [Abstract] [Free Full-text]
34.Skelly, M.M., James, P.D. and Ryder, S.D. (2001) Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. Journal of Hepatology 35(2), 195-199. [Abstract]
35.Smetana, G.W. and Macpherson, D.S. (2003) The case against routine preoperative laboratory testing. Medical Clinics of North America 87(1), 7-40. [Abstract]
36.Sofaer, J.A., Holloway, S.M. and Emery, A.E. (1983) A family study of Paget's disease of bone. Journal of Epidemiology and Community Health 37(3), 226-231. [Abstract] [Free Full-text]
37.Sorbi, D., McGill, D.B., Thistle, J.L. et al. (2000) An assessment of the role of liver biopsies in asymptomatic patients with chronic liver test abnormalities. American Journal of Gastroenterology 95(11), 3206-3210. [Abstract]
38.Teli, M.R., James, O.F., Burt, A.D. et al. (1995a) The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 22(6), 1714-1719. [Abstract]
39.Teli, M.R., Day, C.P., Burt, A.D. et al. (1995b) Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 346(8981), 987-990. [Abstract]
40.Theal, R.M. and Scott, K. (1996) Evaluating asymptomatic patients with abnormal liver function test results. American Family Physician 53(6), 2111-2119. [Abstract]
41.Thomsen, H.F., Hardt, F. and Juhl, E. (1981) Diagnosis of Gilbert's syndrome. Reliability of the caloric restriction and phenobarbital stimulation tests. Scandinavian Journal of Gastroenterology 16(5), 699-703. [Abstract]
42.Titcomb, C.P. (2003) Liver function tests: what is the risk? Journal of Insurance Medicine 35(1), 26-35. [Abstract]
43.Van Hootegem, P., Fevery, J. and Blanckaert, N. (1985) Serum bilirubins in hepatobiliary disease: comparison with other liver function tests and changes in the postobstructive period. Hepatology 5(1), 112-117. [Abstract]
44.Vellenga, C.J., Pauwels, E.K., Bijvoet, O.L. et al. (1984) Untreated Paget disease of bone studied by scintigraphy. Radiology 153(3), 799-805. [Abstract] [Free Full-text]
45.Whitehead, M.W., Hawkes, N.D., Hainsworth, I. and Kingham, J.G. (1999) A prospective study of the causes of notably raised aspartate aminotransferase of liver origin. Gut 45(1), 129-133. [Abstract] [Free Full-text]
46.Wilson, J.W. (1979) Inherited elevation of alkaline phosphatase activity in the absence of disease. New England Journal of Medicine 301(18), 983-984.
47.Young, D.S. (1990) Effects of drugs on clinical laboratory tests. 3rd edn. Washington, D.C.: AACC Press.